SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-97-002876
Filing Date
1997-06-30
Accepted
1997-06-30 00:00:00
Documents
5
Period of Report
1997-06-12
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GENZYME CORPORATION 8-K 12672
2 CONSENT OF COOPERS & LYBRAND, LLP EX-23.1 1294
3 CONSENT OF ARTHUR ANDERSEN, LLP EX-23.2 1086
4 FINANCIAL STATEMENTS OF PHARMAGENICS EX-99.1 103554
5 FINANCIAL STATEMENTS OF GENZYME MOLECULAR ONCOLOGY EX-99.2 102393
  Complete submission text file 0000950135-97-002876.txt   222995
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14680 | Film No.: 97632836
SIC: 2836 Biological Products, (No Diagnostic Substances)